Clinical Drug Experience Knowledgebase

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Colorectal Neoplasms (Phase 2)

Cystic Fibrosis (Phase 1)

Fibrosis (Phase 1)

Gastrointestinal Stromal Tumors (Phase 1)

Leukemia (Phase 2)

Leukemia, Myeloid, Acute (Phase 1)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 2)

Mesothelioma (Phase 1)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Preleukemia (Phase 2)

Syndrome (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Waldenstrom Macroglobulinemia (Phase 1)